News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
FRIEL ROBERT F
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/12/2023 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on NUVASIVE INC
Txns:
| Granted 4,816 options to buy
@ $0 |
|
04/27/2023 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns:
| Granted 616 shares
@ $0 |
|
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/29/2020 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on NUVASIVE INC
Txns:
| Granted 3,095 options to buy
@ $0 |
|
05/14/2020 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on Xylem Inc.
Txns:
| Granted 3,737 shares
@ $0 |
|
05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/27/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2019 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on Xylem Inc.
Txns:
| Granted 1,831 shares
@ $0 |
|
05/10/2019 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on NUVASIVE INC
Txns:
| Granted 2,577 options to buy
@ $0 |
|
02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/03/2018 |
4
| FRIEL ROBERT F (President and CEO) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 2,709 shares
@ $80.001, valued at
$216.7k
Sold 215,870 shares
@ $81.62, valued at
$17.6M
Exercised 2,709 options to buy
@ $26.145, valued at
$70.8k
Exercised 215,870 options to buy
@ $26.145, valued at
$5.6M
|
|
05/10/2018 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on Xylem Inc.
Txns:
| Granted 1,947 shares
@ $0 |
|
05/07/2018 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on NUVASIVE INC
Txns:
| Granted 3,230 options to buy
@ $0 |
|
02/07/2018 |
4
| FRIEL ROBERT F (President and CEO) has filed a Form 4 on PERKINELMER INC
Txns:
| Paid exercise price by delivering 16,374 shares
@ $78.08, valued at
$1.3M
|
|
02/01/2018 |
4
| FRIEL ROBERT F (President and CEO) has filed a Form 4 on PERKINELMER INC
Txns:
| Granted 17,060 shares
@ $0 Granted 75,947 options to buy
@ $81.05, valued at
$6.2M
|
|
05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2017 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on Xylem Inc. |
05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/28/2017 |
4
| FRIEL ROBERT F (President and CEO) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 124,837 shares
@ $60.11, valued at
$7.5M
Exercised 124,837 options to buy
@ $26.58, valued at
$3.3M
|
|
02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/12/2016 |
4
| FRIEL ROBERT F (President and CEO) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 10,685 shares
@ $55.01, valued at
$587.8k
Exercised 10,685 options to buy
@ $21.005, valued at
$224.4k
|
|
05/12/2016 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on Xylem Inc. |
05/09/2016 |
4
| FRIEL ROBERT F (President and CEO) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 4,116 shares
@ $55, valued at
$226.4k
Exercised 4,116 options to buy
@ $21.005, valued at
$86.5k
|
|
|
|
|